Chief Executive Officer · Clover Health Investments, Corp. (CLOV)

Vivek Garipalli

FY2021 is the first fiscal year CompBrief holds for Vivek Garipalli as a named executive officer of Clover Health Investments; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$389,569,439

Salary $0Stock awards $389,569,439

1st of 6 named executive officers at Clover Health Investments by FY2021 total.

6 named officers on file for Clover Health Investments, FY2021

Vivek Garipalli’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CLOV’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Clover Health Investments’s whole pay program stands against its peers

  • Clover Health Investments’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CLOV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Vivek Garipalli’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Vivek Garipalli compensation by year

Clover Health Investments Summary Compensation Table · the one fiscal year held
In US dollars, as Clover Health Investments reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$0
Bonus$0
Stock awards$389,569,439
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$389,569,439

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Clover Health Investments, Corp. DEF 14A filed April 26, 2023, accession 0001801170-23-000031, and prior-year filings.

How this page was built: the Clover Health Investments, Corp. filed document, accession 0001801170-23-000031. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU13,370,793$12,434,837—
PSU7,164,581$6,663,060—
PSU5,571,164$5,181,183—

Per the Outstanding Equity Awards at Fiscal Year-End table in Clover Health Investments, Corp.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

24 Form 4 lines since the FY2021 proxy (filed April 26, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-01-07Exercise or conversion derivative—1,655,949—8,591,093
2026-01-07Exercise or conversion—1,655,949$0.003,512,196
2026-01-07Exercise or conversion derivative—3,342,699—10,247,042
2026-01-07Tax withholding—1,655,949$2.591,856,247
2026-01-07Exercise or conversion derivative—3,342,699—0
2025-08-08Purchase—31,980$2.171,856,247
2025-08-07Purchase—415,000$2.241,824,267
2025-01-07Exercise or conversion—1,670,965$0.003,080,232

The 8 most recent of 24 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Clover Health Investments’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Vivek Garipalli · this pageChief Executive Officer$389,569,439
Andrew ToyPresident$141,987,507
Jamie ReynosoChief Operating Officer$3,048,484
Prabhdeep SinghChief Growth Officer$2,679,325
Mark HerbersInterim Chief Financial Officer$1,034,886
Joseph WagnerFormer Chief Financial Officer$407,342

Board service

Clover Health Investments board · FY2022–FY2025

How this board is paid

Company policy: Clover Health Investments pays directors a $50,000 cash retainer and $200,000 in RSUs. As stated in Clover Health Investments's FY2025 proxy.

The full Clover Health Investments compensation record

free company brief

This page is one person within Clover Health Investments's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Clover Health Investments proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Clover Health Investments's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Vivek Garipalli's compensation dossier · One-time report. No refunds.